87 Mesothelin-targeted immunotherapy CRS-207 plus chemotherapy as treatment for malignant pleural mesothelioma (MPM). (January 2016) - Hassan, R.; Alley, E.; Kindler, H.; Antonia, S.; Jahan, T.; Grous, J.; Honarmand, S.; Mcdougall, K.; Whiting, C.; Nair, N.; Enstrom, A.; Lemmens, E.; et al.